Mito Advocacy

Ask Congress to review the FDA’s decision not to approve elamipretide for Barth Syndrome and encourage thorough review and reform of the FDA’s rare disease therapy evaluation process

Jun 12, 2025

May 30, 2025

The U.S. Department of Defense’s Peer Reviewed Medical Research Program (PRMRP), established in 1999, has supported research across the...

May 29, 2025

May 29, 2025 — Earlier today, the U.S. Food and Drug Administration (FDA) decided against approval of elamipretide for use in patients...

May 5, 2025

Apr 16, 2025

Apr 1, 2025

Mar 10, 2025

Updated 3/12/25, 11amLast night, the House approved the continuing resolution — including the 57% CDMRP cut — to fund the...

Jan 27, 2025

Dec 3, 2024

Nov 25, 2024

With the recent election results, we’ve been getting some inquiries about the impact of a second Trump Administration on mitochondrial disease...